Joesoef Skincare Anti Acne
NDC Package 26050-112-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Joesoef Skincare Anti Acne is a . Marketed by Pt Galenium Pharmasia Laboratories, this product is identified by NDC 26050-112 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
26050-112-01
Package Description
95 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
26050011201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Joesoef Skincare Anti Acne
Dosage Form
-

Regulatory & Marketing

Labeler Name
Pt Galenium Pharmasia Laboratories
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-01-2006
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 26050-112-01 identifies a specific commercial package of 95 ml in 1 bottle of Joesoef Skincare Anti Acne, labeled by Pt Galenium Pharmasia Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pt Galenium Pharmasia Laboratories on October 01, 2006. The current certification is valid through December 31, 2021.

How is this Pt Galenium Pharmasia Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 26050011201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
26050-112-01
11-Digit CMS (5-4-2)
26050-0112-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.